BMC Gastroenterology

official impact factor 2.47

Open Access Highly Access

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

José M Navarro-Jarabo*, Nuria Fernández, Francisca L Sousa, Encarnación Cabrera, Manuel Castro, Luz M Ramírez, Robin Rivera, Esther Ubiña, Francisco Vera, Isabel Méndez, Francisco Rivas-Ruiz, José L Moreno and Emilio Perea-Milla

BMC Gastroenterology 2007, 7:31 doi:10.1186/1471-230X-7-31

Accesses  

  • Last 30 days: 40 accesses
  • Last 365 days: 608 accesses
  • All time: 5570 accesses